# Petri

Investor in Boston, Massachusetts

## About Petri

Petri is a new approach for funding formation-stage startups at the intersection of biology and engineering.

Petri is co-founded by entrepreneurs who have built iconic companies as well as academics who are driving foundational science in bioengineering; together we have deep experience developing ideas into successful companies across human health and sustainability.

We invest pre-seed and seed capital and work one-on-one with founders for 12+ months. We help founders build world-class teams, develop intellectual property, find customers, and raise a subsequent round of financing.

Every Petri company receives access to comprehensive resources and 1:1 coaching to help develop your idea into a company.

— Mentorship Guidance and feedback from an unparalleled network of leading experts

— Peer Community Membership in an elite group of peer founders working to change the world

— Capital Pre-seed capital and access to a vast network of investors

— Partner + Customer Connections Early access and introductions to business development and corporate venture capital groups

— Talent Recruiting Direct access to a talent network from the world’s top universities

## People

- **Tony Kulesa**, Partner

## Key Facts

- **Location:** Boston, Massachusetts
- **Investor Type:** Venture Capital

## Investment Industries

- Biotech
- Other

## How to Contact

Direct messaging, this investor's website, and their LinkedIn and X profiles are available with a paid Ask For Funding plan.

- [See plans and pricing](https://askforfunding.com/pricing)
- Already on a paid plan? [Log in](https://askforfunding.com/users/sign_in)

## More on Ask For Funding

- Full profile: https://askforfunding.com/investor/petri
- More investors: [Biotech Investors in Massachusetts](https://askforfunding.com/site/angel-investors/massachusetts/biotech)
- Find more investors: https://askforfunding.com/search/investors

Ask For Funding (AskForFunding.com) connects entrepreneurs with angel investors, private investors and venture capital firms in the United States, Canada and Australia.
